Caribou Biosciences, Inc. CRBU · SEC Filings

website

Caribou Biosciences, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to pioneerin...

Price0.4198

Market Cap45.38 M

Float104.12 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B5

SHELF OFFERING | Shares amount: 19,230,769 | Share price: $6.50 | Offering amount: $124,999,999.00

Jul 14, 2023

424B5

SHELF OFFERING | Share price: $7.76 | Offering amount: $100,000,000.00

Jul 13, 2023

424B4

OFFERING | Shares amount: 19,000,000 | Share price: $16.00 | Offering amount: $304,000,000.00

Jul 23, 2021

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 5, 2026

S-3

May 2025 SHELF & ATM

May 8, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 10, 2025

S-8

Registration

Mar 11, 2024

S-8

Registration

Mar 9, 2023

S-3

SHELF | ATM | Offering amount: $400,000,000.00 EFFECTIVE

Aug 9, 2022

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Jun 5, 2026

DEFR14A

Form DEFR14A - Revised definitive proxy soliciting materials

May 1, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 24, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 24, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Apr 10, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

May 8, 2025

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

BlackRock, Inc. (Filed by)

Jul 27, 2026

Kelly Timothy P (Reporting)

Feb 27, 2026

144

Form 144 - Report of proposed sale of securities

Feb 25, 2026

144

Form 144 - Report of proposed sale of securities

Feb 25, 2026

144

Form 144 - Report of proposed sale of securities

Feb 25, 2026

Kelly Timothy P (Reporting)

Feb 24, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

May 15, 2025

CORRESP

Form CORRESP - Correspondence

May 13, 2025

LETTER

Form UPLOAD - SEC-generated letter

May 12, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Aug 17, 2022

CORRESP

Form CORRESP - Correspondence

Aug 12, 2022

LETTER

Form UPLOAD - SEC-generated letter

Aug 11, 2022